Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of a patch-based influenza vaccine.

Trial Profile

Phase I trial of a patch-based influenza vaccine.

Phase of Trial: Phase I

Latest Information Update: 11 Dec 2017

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Heat-labile enterotoxin E coli
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Intercell USA; Valneva USA
  • Most Recent Events

    • 11 Dec 2017 According to a Valneva media release, Intercell USA changed its name to Valneva USA.
    • 15 Nov 2012 Status changed from active, no longer recruiting to completed.
    • 25 May 2007 Status change from inititated to in progress; interim results reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top